Walleye Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Walleye Trading’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-70,990	Closed	-$2.26M	–	3964
2026 Q1	$1.88M	Sell	70,990 -17,849	-20%	-$523K	﹤0.01%	1750
2025 Q4	$2.57M	Buy	88,839 +61,025	+219%	+$1.83M	﹤0.01%	1735
2025 Q3	$772K	Buy	27,814 +19,488	+234%	+$492K	﹤0.01%	2442
2025 Q2	$203K	Buy	+8,326	New	+$182K	﹤0.01%	3230
2024 Q2	–	Sell	-29,807	Closed	-$752K	–	4244
2024 Q1	$857K	Sell	29,807 -92,078	-76%	-$2.77M	﹤0.01%	2378
2023 Q4	$4M	Buy	+121,885	New	+$3.31M	0.01%	1387
2022 Q3	–	Sell	-11,430	Closed	-$420K	–	5007
2022 Q2	$360K	Buy	+11,430	New	+$400K	﹤0.01%	3213
2021 Q4	–	Sell	-12,389	Closed	-$926K	–	5315
2021 Q3	$926K	Buy	+12,389	New	+$1.04M	﹤0.01%	2284

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Walleye Trading's ARKG Position: Q2 2026 in Review

Walleye Trading sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 70,990 shares — an estimated $2.26M sold.

Walleye Trading first reported a position in ARKG in Q3 2021 and held it in 8 quarters. The position peaked at $4M in Q4 2023. 157 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Walleye Trading reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Walleye Trading sold 70,990 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $2.26M.
Walleye Trading first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 8 quarters.
Walleye Trading's ARK Genomic Revolution ETF position peaked at $4M in Q4 2023.
157 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.